Today’s bell at the Frankfurt Stock Exchange marks a milestone made possible by the trust of our investors, partners, and advisors who share our vision of a more connected, intelligent future of precision medicine.
Leo International Precision Healthcare AG (LEOW) is laying the foundation for an active healthcare platform that brings together promising AI-driven innovations across diagnostics, therapeutics, and personalized care, bridging continents, disciplines, and ideas. Our goal is to translate scientific excellence into sustainable value and to create new pathways for collaboration between European investors and global health innovators.
This moment is both a celebration and a beginning – an invitation to grow with purpose, integrity, and a shared vision.
